Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis

Kidney International

Volumn 72, Issue 11, 2007, Pages 1330-1335

  Usatii, M ^a,b   Rousseau, L ^a,b   Demers, C ^a,b   Petit, J L ^a,b   Brossard, J H ^a,b   Gascon Barre M ^a,b   Lavigne, J R ^c   Zahradnik, R J ^c   Nemeth, E F ^d   D'Amour, P ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Immutopics International   (United States)

^d NPS Pharmaceuticals   (Canada)

Author keywords

1,25(OH)2 vitamin D; CYP27B1; Parathyroid hormone; Renal failure

Indexed keywords

CALCITRIOL; PARATHYROID HORMONE; PHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM ABSORPTION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HORMONE INHIBITION; HYPOCALCEMIA; KIDNEY FAILURE; MALE; NONHUMAN; PARATHYROIDECTOMY; PRIORITY JOURNAL; RAT; SYNTHESIS;

EID: 36248990247     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002532     Document Type: Article

References (27)

1. Brossard JH, Cloutier M, Roy L et al. Accumulation of non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 2000; 81: 3923-3929.
2. Murray TM, Rao LG, Divieti P et al. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 2005; 26: 78-113.
3. Slatopolsky E, Finch J, Clay P et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000; 58: 753-761.
4. Nguyen-Yamamoto L, Rousseau L, Brossard JH et al. Synthetic carboxyl-terminal fragments of PTH decrease ionized calcium concentration in rats by acting on a receptor different from the PTH/PTHrP receptor. Endocrinology 2001; 142: 1386-1392.
5. Langub MC, Monier-Faugere MC, Wang G et al. Administration of PTH-(7-84) antagonizes the effects of PTH-(1-84) on bone in rats with moderate renal failure. Endocrinology 2003; 144: 1135-1138.
6. Divieti P, John MR, Jüppner H et al. Human PTH-(7-84) inhibits bone resorption in vitro via actions independent of the type 1 PTH/PTHrP receptor. Endocrinology 2002; 143: 171-176.
7. Divieti P, Inomata N, Chapin K et al. Receptors for the carboxyl-terminal region of PTH(1-84) are highly expressed in osteocytic cells. Endocrinology 2001; 142: 916-925.
8. Inomata N, Akiyama M, Kubota N et al. Characterization of a novel PTH-receptor with specificity for the carboxyl-terminal region of PTH(1-84). Endocrinology 1995; 136: 4732-4740.
9. Divieti P, Geller AI, Suliman G et al. Receptors specific for the carboxyl-terminal region of parathyroid hormone on bone-derived cells: determinants of ligand binding and bioactivity. Endocrinology 2005; 146: 1863-1870.
10. Cloutier M, Brossard JH, Gascon-Barré M et al. Lack of involution of hyperplastic parathyroid glands in dogs. Adaptation via a decrease in the calcium stimulation set point and a change in secretion profile. J Bone Miner Res 1994; 9: 621-629.
11. Cloutier M, Gagnon Y, Brossard JH et al. Adaptation of parathyroid function to IV 1,25-dihydroxyvitamin D3 or partial parathyroidectomy in normal dogs. J Endocrinol 1997; 155: 133-141.
12. Hanley DA, Matus S, Cheng H. Effect of 1,25-dihydroxyvitamin D3 on secretion of parathyroid hormone fragments in cultured bovine parathyroid cells. Clin Invest Med 1996; 19: S23.
13. Trechsel U, Eisman JA, Fischer JA et al. Calcium-dependent, parathyroid hormone-independent regulation of 1,25-dihydroxyvitamin D. Am J Physiol 1980; 239: E119-E124.
14. Hulter HN, Halloran BP, Toto RD et al. Long-term control of plasma calcitriol concentration in dogs and humans: dominant role of plasma calcium concentration in experimental hyperparathyroidism. J Clin Invest 1985; 76: 695-702.
15. 3 independently of parathyroid hormone and phosphorus in the rat. J Clin Invest 1985; 76: 1599-1604.
16. 3 by calcium in the parathyroidectomized, parathyroid hormone-replete rat. J Bone Miner Res 1989; 4: 929-935.
17. Clements MR, Johnson L, Fraser DR. A new mechanism for induced vitamin D deficiency in calcium deprivation. Nature 1987; 125: 62-64.
18. 3 production in adult rats. Am J Physiol 2003; 284: F1032-F1036.
19. Sneddon WB, Syme CA, Bisello A et al. Activation-independent parathyroid hormone receptor internalization is regulated by NHERF1 (EBP50). J Biol Chem 2003; 278: 43787-43796.
20. Silver J, Naveh-Many T, Mayer H et al. Regulation by vitamin D metabolites of parathyroid gene transcription in vivo in the rat. J Clin Invest 1986; 78: 1296-1301.
21. St John A, Thomas MB, Cavies CP et al. Determinants of intact parathyroid hormone and free 1,25-dihydroxyvitamin D levels in mild and moderate renal failure. Nephron 1992; 61: 422-427.
22. Pitts TO, Piraino BH, Mitro R et al. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure. J Clin Endocrinol Metab 1988; 67: 876-881.
23. Brossard JH, Lepage R, Cardinal H et al. Influence of glomerular filtration rate on non-(1-84) parathyroid hormone (PTH) detected by intact PTH assays. Clin Chem 2000; 46: 697-703.
24. D'Amour P, Brossard JH, Rousseau L et al. Structure of non-(1-84) PTH fragments secreted by parathyroid glands in primary and secondary hyperparathyroidism. Kidney Int 2005; 68: 998-1007.
25. 3 and calcitriol administration in vivo. J Bone Miner Res 1995; 10: 1148-1157.
26. St-Arnaud R, Messerlian S, Moir JM et al. The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 1997; 12: 1552-1559.
27. Tso JY, Sun XH, Kao TH et al. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acids Res 1985; 13: 2485-2502.